Supported by

Tricuspid / Pulmonary valve

Find all the latest content on tricuspid or pulmonary valve published on this website.

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Tricuspid / Pulmonary valve

466 results

2023 ESC Guidelines for the management of Endocarditis

24 Jul 2023

These guidelines have been developed to support healthcare professionals with the diagnosis and management of patients with infective endocarditis.

Alex Sticchi interviews Victoria Delgado on the updated version which she presented during the ESC Congress 2023 in Amsterdam: Discover the key elements and take-home messages.

Alessandro Sticchi

Author

Alessandro Sticchi

Author

Victoria Delgado
2023 ESC Guidelines for the management of Endocarditis

The TRILUMINATE pivotal trial: impact on practice and perspectives

19 Jul 2023

Watch the replay of this webinar with F. Praz, F. Maisano, V. Delgado, R. Hahn, M. Metra and P. Sorajja and learn about the latest randomised results on the treatment of tricuspid regurgitation and so much more!

The TRILUMINATE pivotal trial: impact on practice and perspectives

Atrial functional tricuspid regurgitation: Importance of atrial fibrillation and right atrial remodeling and prognostic significance

18 Jul 2023

- When tricuspid regurgitation “begets” tricuspid regurgitation -

Edoardo Zancanaro

Reviewer

Edoardo Zancanaro
Atrial functional tricuspid regurgitation importance of atrial fibrillation and right atrial remodeling and prognostic significance. When tricuspid regurgitation “begets” tricuspid regurgitation

Timing of intervention in patients with severe tricuspid regurgitation

30 Aug 2023

Alex Sticchi interviews Julien Dreyfus about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam, which suggests that, in patients with severe TR, a curative intervention should be considered at an early stage of the disease as assessed by...

Alessandro Sticchi

Author

Alessandro Sticchi
Julien Dreyfus

Author

Julien Dreyfus
Timing of intervention in patients with severe tricuspid regurgitation

Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study

12 Jun 2023

The aim of the b-RIGHT study was to assess the safety and performance of T-TEER using the TriClip (Abbott) in a contemporary, real-world setting...

Jonathan Curio

Reviewer

Jonathan Curio
Fabien Praz

Reviewer

Fabien Praz
Mirjam Wild

Reviewer

Mirjam Wild
Short-term outcomes of tricuspid edge-to-edge repair in clinical practice – bRIGHT study

Emerging options for patients with tricuspid regurgitation: a case-based discussion

19 May 2023 – From EuroPCR 2023

Want to view or revisit the key messages shared during this session on innovations in tricuspid regurgitation? Consult the slides of the topos presented by the speakers and discover what's essential to remember about the different entities of regurgitation, the potential and limitations of TTVR, patient...

Tricuspid regurgitation

EuroPCR 2023 Highlights: Interventions for Valvular Disease

20 May 2023 – From EuroPCR 2023

Nicolas Dumonteil and Bernard Prendergast join Christopher Cook in the PCR recording studio to talk about their personal highlights from another fantastic edition of EuroPCR. From the simulation programme - a key activity of PCR Courses - to the traditional learning sessions by and for the...

EuroPCR 2023 Highlights on interventions for valvular disease

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

17 May 2023 – From EuroPCR 2023

Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.

To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.

The content...

Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

Valvular heart disease: novel transcatheter approaches

18 May 2023 – From EuroPCR 2023

Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.

Valvular heart disease: novel transcatheter approaches

Pivotal momentum for tricuspid valve interventions (Episode 1: the right side)

18 May 2023 – From EuroPCR 2023

Based on an in-depth review of the data from TRILUMINATE pivotal, a randomized trial whose findings were recently published in the NEW ENGLAND JOURNAL of MEDICINE, this lecture explains how these results will impact clinical practice in the treatment of tricuspid regurgitation. Join the speakers and...

Pivotal momentum for